Recent Posts
- Dr. Vince Clinical Research Announces Dosing of Aclaris Therapeutics’ Phase 1 MAD Study of ATI-2138
- Dr. Vince Clinical Research Strengthens Investigator Team with the Addition of George Atiee, MD
- Dr. Vince Clinical Research Announces Dosing of Ensysce’s PF614 Compound in Human Abuse Potential Trial
- Cingulate Completes Fed/Fast Study Assessing Food Effect with CTx-1301, Lead Candidate for Treatment of ADHD
- Dr. Vince Clinical Research Opens Industry-Leading Clinical Pharmacology Unit
Recent Comments